These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15597617)

  • 1. Current concepts and future approaches to the development of autologous/autogenous vaccines for veterinary use.
    Tollis M
    Dev Biol (Basel); 2004; 117():55-60. PubMed ID: 15597617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Veterinary autogenous vaccines.
    Hera A; Bures J
    Dev Biol (Basel); 2004; 117():19-25. PubMed ID: 15597612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory requirements for vaccine authorisation.
    Jones PG; Cowan G; Gravendyck M; Nagata T; Robinson S; Waits M
    Rev Sci Tech; 2007 Aug; 26(2):379-93. PubMed ID: 17892159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines for minor use and minor species: technical difficulties to solve and consequences in legal definitions.
    Vannier P
    Dev Biol (Basel); 2004; 117():137-40. PubMed ID: 15597630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines for minor species and minor indications: current situation and concepts in Germany--feasible approaches for the future--authorities' view.
    Werner E
    Dev Biol (Basel); 2004; 117():165-70. PubMed ID: 15597635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future European system for the free circulation of veterinary vaccines in Europe.
    Hankin R
    Dev Biol Stand; 1992; 79():3-9. PubMed ID: 1286761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency assays for therapeutic live whole cell cancer vaccines.
    Petricciani J; Egan W; Vicari G; Furesz J; Schild G
    Biologicals; 2007 Apr; 35(2):107-13. PubMed ID: 16882459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of immunity (DOI)--The regulatory issues.
    Gaskell RM; Dawson S; Radford AD
    Vet Microbiol; 2006 Oct; 117(1):80-5. PubMed ID: 16723198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of product batches (before and after registration). The French approach.
    Vannier P
    Dev Biol Stand; 1992; 79():179-82. PubMed ID: 1286755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regulatory requirements regarding cell-based medicinal products for human and veterinary use - a comparison].
    Kuhlmann-Gottke J; Duchow K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1299-305. PubMed ID: 26369765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Authorisation within the European Union of vaccines against antigenically variable viruses responsible for major epizootic diseases.
    Mackay DK
    Rev Sci Tech; 2007 Aug; 26(2):421-8. PubMed ID: 17892162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good manufacturing practice for immunological veterinary medicinal products.
    Todd JI
    Rev Sci Tech; 2007 Apr; 26(1):135-45. PubMed ID: 17633298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of autogenous biologicals in the United States.
    Schmellik-Sandage CS; Hill RE
    Dev Biol (Basel); 2004; 117():9-13. PubMed ID: 15597610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A refined symptom-based approach to diagnose pulmonary tuberculosis in children.
    Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N
    Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minor species/minor indications: legal provisions, definition criteria and policies to be considered.
    Papadopoulos O
    Dev Biol (Basel); 2004; 117():131-5. PubMed ID: 15597629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The legal foundation of the production and use of herd-specific vaccines in Europe.
    Attia Y; Schmerold I; Hönel A
    Vaccine; 2013 Aug; 31(36):3651-5. PubMed ID: 23764532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.